TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8967666

Group type: EXPERIMENTAL
Intervention: 1.4 mg of rhGH once daily plus placebo twice daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 5 mg of rhIGF‐1 twice daily plus placebo once daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 5 mg of rhIGF‐1 twice daily plus 1.4 mg of rhGH once daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo three times daily
Number of subjects: 60
Study: 1797910

Group type: EXPERIMENTAL
Intervention: Indomethacin 0.1%
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 6275871

Group type: EXPERIMENTAL
Intervention: Neostigmine 0.35 mg kg‐1 with atropine 0.0175 mg kg‐1 in hypercarbia group
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Neostigmine 0.35 mg kg‐1 with atropine 0.0175 mg kg‐1 in hypocarbia group
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Neostigmine 0.35 mg kg‐1 with atropine 0.0175 mg kg‐1 in normocarbia group
Number of subjects: 21

Group type: COMPARATOR
Intervention: Hypercarbia group
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 21
Study: 31556653

Group type: EXPERIMENTAL
Intervention: Resource priming condition
Number of subjects: 57

Group type: COMPARATOR
Intervention: Adherence priming condition
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Both conditions (resource priming and adherence priming)
Number of subjects: 57
Study: 27573387

Group type: EXPERIMENTAL
Intervention: 30 % trisodium citrate (TSC30 %)
Number of subjects: 464

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 464
Study: 26940892

Group type: EXPERIMENTAL
Intervention: Behavioral therapy (BT)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Zolpidem
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Zolpidem or Trazodone (second stage therapy)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Behavioral therapy (BT) or Cognitive therapy (CT) (second stage therapy)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Sleep parameters from daily sleep diaries and polysomnography
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Adverse events, dropout rates, treatment acceptability
Number of subjects: 224
Study: 24630938

Group type: EXPERIMENTAL
Intervention: S/S genotype
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: L/L genotype
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: 5-HTTLPR genotype by trait neuroticism interaction
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control day
Number of subjects: 94
Study: 22089461

Group type: EXPERIMENTAL
Intervention: Civamide cream 0.075%
Number of subjects: 695

Group type: COMPARATOR
Intervention: Civamide cream 0.01% (control)
Number of subjects: 695
Study: 19294889

Group type: EXPERIMENTAL
Intervention: Group education program with personal rehabilitation (3 group lectures on health education specific to IPD and 24 half-hour individualized rehabilitation sessions over 8 weeks)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Group education program with personal rehabilitation
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 44
Study: 17557972

Group type: EXPERIMENTAL
Intervention: Intervention programs (multicomponent strategies, parental involvement)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Intervention programs
Number of subjects: 7

Group type: COMPARATOR
Intervention: Prevention programs
Number of subjects: 7
Study: 14763634

Group type: EXPERIMENTAL
Intervention: Immediate program group (n = 23)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Delayed program control group (n = 24)
Number of subjects: 47
Study: 11988188

Group type: EXPERIMENTAL
Intervention: Oral nitroglycerin 400 microg
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Cold stress
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 55
Study: 9884140

Group type: EXPERIMENTAL
Intervention: Low alcohol beer (0.9%, v/v) consumed for 4 weeks
Number of subjects: 55

Group type: COMPARATOR
Intervention: Full-strength beer (4.9%, v/v) consumed for 4 weeks
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Change in CDT
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Change in gamma-GT
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 10% change in CDT
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 10% change in gamma-GT
Number of subjects: 55
Study: 7702049

Group type: EXPERIMENTAL
Intervention: r‐HuEPO treatment
Number of subjects: 83

Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 83
Study: 1369848

Group type: EXPERIMENTAL
Intervention: Operated hips after Mc Kee‐Farrar total hip arthroplasty
Number of subjects: 84

Group type: COMPARATOR
Intervention: Non-operated arthritic hips
Number of subjects: 84

Group type: COMPARATOR
Intervention: Normal hips
Number of subjects: 84
Study: 45602

Group type: EXPERIMENTAL
Intervention: Subunit vaccine at 600 CCA
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Subunit vaccine at 200 CCA
Number of subjects: 202

Group type: COMPARATOR
Intervention: Whole-virus vaccine at 200 CCA
Number of subjects: 202
Study: 30958054

Group type: EXPERIMENTAL
Intervention: RS-BFR (40% arterial occlusion pressure)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: RSH (systemic normobaric hypoxia, FiO2=14%)
Number of subjects: 8

Group type: COMPARATOR
Intervention: RSN (normoxia)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: RS-BFR and RSH
Number of subjects: 8
Study: 28196523

Group type: EXPERIMENTAL
Intervention: Self-management education program
Number of subjects: 342
Study: 26502971

Group type: EXPERIMENTAL
Intervention: Magnesium treatment
Number of subjects: 616

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 616
Study: 23635906

Group type: EXPERIMENTAL
Intervention: Independent component neurofeedback (NFB)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham feedback (SFB)
Number of subjects: 20
Study: 21768318

Group type: EXPERIMENTAL
Intervention: Frenotomy
Number of subjects: 58

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 58
Study: 19620428

Group type: EXPERIMENTAL
Intervention: Dual-head SPECT imaging
Number of subjects: 40

Group type: COMPARATOR
Intervention: Planar imaging
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison of SPECT vs planar imaging
Number of subjects: 40
Study: 18379519

Group type: EXPERIMENTAL
Intervention: Local injections of tolperisone (midocalm) combined with tractional therapy, 3-6 injections
Number of subjects: 49

Group type: COMPARATOR
Intervention: Tractional therapy without midocalm (placebo)
Number of subjects: 49
Study: 16116148

Group type: EXPERIMENTAL
Intervention: Peer-counseling program with up to six telephone calls from a trained childhood cancer survivor, tailored materials, and free nicotine replacement therapy
Number of subjects: 796

Group type: COMPARATOR
Intervention: Self-help program
Number of subjects: 796
Study: 11992864

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (Viagra) 100 mg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 9500298

Group type: EXPERIMENTAL
Intervention: Salmeterol
Number of subjects: 7

Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Combination of salbutamol and salmeterol
Number of subjects: 7
Study: 7587211

Group type: EXPERIMENTAL
Intervention: Post hoc covariate adjustment in RCTs
Number of subjects: 0
Study: 2570012

Group type: EXPERIMENTAL
Intervention: 300 mg nizatidine nocte
Number of subjects: 367

Group type: COMPARATOR
Intervention: 300 mg ranitidine nocte
Number of subjects: 367
Study: 4605245

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg iv
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dummy injection (Control)
Number of subjects: 20
Study: 30646113

Group type: EXPERIMENTAL
Intervention: Theory-based, culturally adapted, 6-session HIV/sexually transmitted disease risk-reduction intervention (Let Us Protect Our Future intervention)
Number of subjects: 1052

Group type: COMPARATOR
Intervention: Attention-matched, chronic disease prevention control intervention
Number of subjects: 1052
Study: 28535825

Group type: EXPERIMENTAL
Intervention: Increased fruit and vegetable consumption
Number of subjects: 0
Study: 26166657

Group type: EXPERIMENTAL
Intervention: General anesthesia combined with intercostal nerve block
Number of subjects: 80

Group type: COMPARATOR
Intervention: Epidural anesthesia
Number of subjects: 80
Study: 24139323

Group type: EXPERIMENTAL
Intervention: Strongest Families Smart Website intervention with weekly telephone coaching sessions
Number of subjects: 100

Group type: COMPARATOR
Intervention: Education Control condition with access to a static website with parenting tips
Number of subjects: 100
Study: 21913826

Group type: EXPERIMENTAL
Intervention: Bortezomib plus Melphalan and Prednisone (VMP)
Number of subjects: 682

Group type: COMPARATOR
Intervention: Melphalan and Prednisone (MP) alone
Number of subjects: 682
Study: 18326055

Group type: EXPERIMENTAL
Intervention: Forward reaching tasks with low target height (109 cm) and self-selected speed
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Forward reaching tasks with high target height (153 cm) and as fast as possible speed
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Bland-Altman analysis
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Kinematic outcome measures (e.g., peak hand velocity, endpoint error, reach extent, maximum shoulder flexion range of motion, minimum elbow extension range of motion)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Peak hand velocity, time to peak hand velocity, and movement time
Number of subjects: 14
Study: 16895628

Group type: EXPERIMENTAL
Intervention: Letrozole (group A)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No letrozole (group B)
Number of subjects: 20
Study: 12706674

Group type: EXPERIMENTAL
Intervention: PCV-OMPC (lot 1) with Hib-CRM(197) (TETRAMUNE)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: PCV-OMPC (lot 2) with Hib-CRM(197) (TETRAMUNE)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: PCV-OMPC (lot 1) with Hib-OMPC (Group 2)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: PCV-OMPC (lot 1)
Number of subjects: 120
Study: 11142419

Group type: EXPERIMENTAL
Intervention: High waist-to-hip ratio (WHR > 0.92)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: High hip circumference (>97.4 cm)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Height, usual adult weight, preadult and usual adult BMI
Number of subjects: 238
Study: 8886999

Group type: EXPERIMENTAL
Intervention: IL-10 (1 microgram/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IL-10 (10 micrograms/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IL-10 (25 micrograms/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2058593

Group type: EXPERIMENTAL
Intervention: Soy-protein beverage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cow-milk protein
Number of subjects: 0
Study: 6355314

Group type: EXPERIMENTAL
Intervention: Erythromycin (500 mg, 10-day course, four times daily)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Rosaramicin (250 mg, 10-day course, four times daily)
Number of subjects: 99
Study: 30395052

Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg·kg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 30270178

Group type: COMPARATOR
Intervention: High hsCRP (groups C and D)
Number of subjects: 1734

Group type: EXPERIMENTAL
Intervention: Low hsCRP (group A)
Number of subjects: 1734

Group type: COMPARATOR
Intervention: Low hsCRP with renal impairment (group B)
Number of subjects: 1734
Study: 27079848

Group type: EXPERIMENTAL
Intervention: High dose IgG (M = 794.93; SD = 90.48)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low dose IgG (M = 283.89; SD = 71.10)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Single-case experimental designs (MD = 495.00; SE = 54.41)
Number of subjects: 12
Study: 24791643

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Imagery Relief Therapy (IRT)
Number of subjects: 164
Study: 22968245

Group type: EXPERIMENTAL
Intervention: Nutritional support following new clinical guidelines from admission to five days postoperatively
Number of subjects: 88

Group type: COMPARATOR
Intervention: Regular nutritional support pre- and postoperatively (Control)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Nutritional support following new clinical guidelines
Number of subjects: 88

Group type: COMPARATOR
Intervention: Nutritional support (both groups)
Number of subjects: 88
Study: 19560905

Group type: EXPERIMENTAL
Intervention: Lidocaine (0.5 mg/kg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Procaine (0.5 mg/kg and 1.0 mg/kg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 9
Study: 18044436

Group type: EXPERIMENTAL
Intervention: Vaccination (three doses at 3-week intervals)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 288
Study: 16108507

Group type: EXPERIMENTAL
Intervention: Phloroglucinol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 12164741

Group type: EXPERIMENTAL
Intervention: Conventional diamond fraise dermabrasion
Number of subjects: 21

Group type: COMPARATOR
Intervention: Manual dermabrasion with medium-grade drywall sanding screen
Number of subjects: 21
Study: 9933773

Group type: EXPERIMENTAL
Intervention: Standardised Nidek EAS‐1000 densitometric analysis of the lens
Number of subjects: 1204

Group type: COMPARATOR
Intervention: Clinical assessment of the nucleus
Number of subjects: 1204
Study: 7473002

Group type: EXPERIMENTAL
Intervention: Ethanol-containing mouthrinses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ethanol/water controls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clear Choice mouthrinse (marketed product)
Number of subjects: 0
Study: 2097484

Group type: COMPARATOR
Intervention: 2 mg epidural morphine in 2 ml saline
Number of subjects: 90

Group type: COMPARATOR
Intervention: 2 mg epidural morphine in 10 ml saline
Number of subjects: 90

Group type: COMPARATOR
Intervention: 2 mg epidural morphine in 20 ml saline
Number of subjects: 90
Study: 7027745

Group type: EXPERIMENTAL
Intervention: i.v. infusion of verapamil during standardized oral glucose load
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: oral verapamil treatment after one week during standardized oral glucose load
Number of subjects: 21

Group type: COMPARATOR
Intervention: oral placebo during standardized oral glucose load
Number of subjects: 21
Study: 31689758

Group type: EXPERIMENTAL
Intervention: Comprehensive education and care (CEC) program
Number of subjects: 136

Group type: COMPARATOR
Intervention: Basic health education and rehabilitation
Number of subjects: 136
Study: 29750673

Group type: EXPERIMENTAL
Intervention: Radiotherapy and temozolomide
Number of subjects: 111
Study: 26796950

Group type: EXPERIMENTAL
Intervention: Framing the decision as the patient's vs the surrogate's (25% vs 36%)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Describing the alternative to CPR as 'allow natural death' instead of 'do not resuscitate' (25% vs 37%)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Overall optimism bias (30% of 220)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Accurate recollection of physician's estimate (32% of 173)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Emotion priming
Number of subjects: 220

Group type: COMPARATOR
Intervention: Physician attention to emotion
Number of subjects: 220

Group type: COMPARATOR
Intervention: Framing of CPR as the social norm
Number of subjects: 220
Study: 25280810

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention (What Were We Thinking) for the prevention of postnatal mental health problems
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 22357413

Group type: EXPERIMENTAL
Intervention: Aliskiren 300 mg for 12 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perindopril 10 mg for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19966850

Group type: EXPERIMENTAL
Intervention: Antigenemia group
Number of subjects: 88

Group type: COMPARATOR
Intervention: PCR group
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 88
Study: 17581448

Group type: COMPARATOR
Intervention: Immediate-release methylphenidate (MPH-IR) at doses of 0.1, 0.3, and 0.5 mg/kg twice daily for 2 weeks.
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 15248531

Group type: EXPERIMENTAL
Intervention: Machine learning approach using adapted tight frame decompositions and support vector machines with radial kernels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Machine learning approach
Number of subjects: 0
Study: 11756063

Group type: COMPARATOR
Intervention: Control-1 (sterol-free)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Sterol ester-1 (2.3 g plant sterol esters)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Stanol ester-1 (2.5 g plant stanol esters)
Number of subjects: 46
Study: 9690243

Group type: EXPERIMENTAL
Intervention: Bromfenac 5 mg
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Bromfenac 25 mg
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Bromfenac 50 mg
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Bromfenac 100 mg
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Bromfenac 200 mg
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study: 8106772

Group type: EXPERIMENTAL
Intervention: Pyrimethamine, 25 mg thrice weekly
Number of subjects: 335

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 335

Group type: COMPARATOR
Intervention: Aerosolized pentamidine
Number of subjects: 335
Study: 2669218

Group type: COMPARATOR
Intervention: Prednisolone only series (60 mg daily for one month, then reduced to 20 mg on alternate days)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide-prednisolone series (100-120 mg cyclophosphamide daily plus 20 mg prednisolone on alternate days)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Death or failure of first treatment regimen
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Total lung capacity (TLC) on admission
Number of subjects: 43
Study: 58317

Group type: EXPERIMENTAL
Intervention: Armovical spatula
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ayre's spatula
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sampling cervix twice
Number of subjects: 0
Study: 31520538

Group type: EXPERIMENTAL
Intervention: Supervised exercise
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Bite splint therapy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Home exercise
Number of subjects: 90
Study: 30786914

Group type: EXPERIMENTAL
Intervention: Accuhaler
Number of subjects: 0

Group type: COMPARATOR
Intervention: MDI/s
Number of subjects: 0
Study: 28074796

Group type: EXPERIMENTAL
Intervention: Low-intensity laser therapy (660 NM, spatial average energy fluency of 1.06 J/cm2)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study: 25488186

Group type: EXPERIMENTAL
Intervention: Dual transcranial direct current stimulation applied bilaterally over the primary motor cortex during motor skill learning with the paretic upper limb
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Dual transcranial direct current stimulation
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 19
Study: 24622367

Group type: EXPERIMENTAL
Intervention: Mobile phone messaging intervention
Number of subjects: 537

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 537
Study: 21159483

Group type: EXPERIMENTAL
Intervention: Post-intervention pain control self-efficacy
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Post-intervention communication self-efficacy
Number of subjects: 244
Study: 19492956

Group type: EXPERIMENTAL
Intervention: 1-day application of topical 0.5% moxifloxacin, 4 times a day for 1 day, n = 63
Number of subjects: 144
Study: 16988065

Group type: COMPARATOR
Intervention: Racial/Ethnic minority groups (Hispanic, Black, Asian, Native American, Other)
Number of subjects: 6677

Group type: COMPARATOR
Intervention: Racial/Ethnic minority groups (Black)
Number of subjects: 6677

Group type: COMPARATOR
Intervention: Racial/Ethnic minority groups (Asian)
Number of subjects: 6677

Group type: COMPARATOR
Intervention: Racial/Ethnic minority groups (Native American)
Number of subjects: 6677

Group type: COMPARATOR
Intervention: Racial/Ethnic minority groups (Other)
Number of subjects: 6677
Study: 15050762

Group type: EXPERIMENTAL
Intervention: ETT palpation and adjustment (Treatment)
Number of subjects: 55

Group type: COMPARATOR
Intervention: ETT palpation and non-adjustment (Controls)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: ETT palpation
Number of subjects: 55
Study: 17767063

Group type: EXPERIMENTAL
Intervention: Diet control group (low-salt, low-cholesterol, low-calorie, high-cellulose diet)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination therapy group (diet control combined with aerobic exercises)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Aerobic exercise group (30 minutes, 3-5 times per week for 12 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (20 healthy subjects)
Number of subjects: 60
Study: 10394257

Group type: EXPERIMENTAL
Intervention: 10 mg of bisoprolol
Number of subjects: 54

Group type: COMPARATOR
Intervention: 240 mg of verapamil LP
Number of subjects: 54
Study: 8893576

Group type: EXPERIMENTAL
Intervention: FUT‐175 (10 mg/L) during CPB
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard CPB sets (C)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Biocompatible CPB sets (B)
Number of subjects: 45
Study: 1886961

Group type: EXPERIMENTAL
Intervention: Standard stimuli (100‐ms, 1000 Hz, 90dB sinusoidal tone bursts)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Frequency deviant (1500 Hz)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensity deviant (67dB SPL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Duration deviant (50 ms)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: N100m to standards and deviants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mismatch fields
Number of subjects: 0